Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_provenance.
- NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_assertion description "[Thus, BMP7 can still counteract the epithelial-to-mesenchymal transition process in the metastatic tumor, positioning BMP7 as a novel therapeutic molecule for treatment of metastatic bone disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_provenance.
- NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_assertion evidence source_evidence_literature NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_provenance.
- NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_assertion SIO_000772 17724140 NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_provenance.
- NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_assertion wasDerivedFrom befree-20140225 NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_provenance.
- NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_assertion wasGeneratedBy ECO_0000203 NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP442466.RAuTtEJ2mxvh4xP_s_d-TzC7QefZYNqitQtNuD2MJClR0130_provenance.